SHOP VIE Week ended 07 Aug 2026

Weekly Investor Report

Redcare Pharmacy NV · Healthcare · Pharmaceutical Retailers

Open interactive chart View report data
Latest close 63.00 EUR
1.4% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 17.0% above the Trend Line and sits at 45.0% of its 52-week range. The latest completed week returned 1.4%, after a 1.9% four-week move. The latest news-sentiment score is 52/100.

Setup score 36 out of 100
Latest Close 63.00 EUR 7 Aug 2026
1W Return 1.4% latest completed week
4W Return 1.9% short-term follow-through
12W Return 35.7% quarterly tape
Trend Breadth 3.8% 2 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • The trend backdrop is active with a 2-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.4% Latest completed week; four-week move 1.9%. Indicator stack 9/71 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 52/100 7 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 17.0% above the Trend Line and sits at 45.0% of its 52-week range. The latest completed week returned 1.4%, after a 1.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3412-week average 0.16

12-week confirmation

Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.34Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 1.9% over four weeks, 35.7% over 12 weeks, and -38.3% over one year. The current trend has remained active for 2 consecutive weeks.

Performance by holding period

1W1.4%
4W1.9%
12W35.7%
26W-3.2%
52W-38.3%
Active trend streak2 weeks
Active weeks in one year2
Trend breadth3.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.20Latest activity-pressure read.
Pressure change-10.8%Four-week change in activity pressure.
Leadership-18.56Latest relative-leadership reading.
RS change24.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 7 relevant articles.

1 positive · 6 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-38.8%Distance below the 52-week high.
13-week volatility11.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+35.2%Week of 19 Jun.
Worst week-30.8%Week of 6 Mar.
Latest week+1.4%Week of 7 Aug.

Shape of recent returns

Strong gains9
Modest gains2
Flat weeks0
Modest losses6
Sharp losses9
Recent vol11.3%13-week weekly-return volatility.
Base vol10.2%52-week weekly-return volatility.
Up/down split22/29Count of positive and negative weeks in the 52-week window.
Average skew7.9% / -6.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

IndustryAT Pharmaceutical Retailers
4-week rank1 / 1
Group average1.9%
Trend breadth100.0%
Trend100.0%active weekly trend signals
MD100.0%positive activity pressure
RS0.0%positive relative leadership

Four-week leaders

SHOP · VIE1.9%
08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape29/100

Trend, activity pressure, participation, and risk combine to a 29/100 tape read.

 Indicator analysis40/100

Latest 12-week confirmation: trend 2/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.34; No reversal markers Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment52/100

Weighted news tone is neutral across 7 relevant articles.

Here's What Analysts Are Forecasting For Redcare Pharmacy NV (ETR:RDC) After Its Second-Quarter Results Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202663.00 EUR1.4%53.87 EUR103.6 EUR1.20-18.561.0KOn
31 Jul 202662.10 EUR-5.2%53.96 EUR103.9 EUR1.37-18.932.5KOn
24 Jul 202665.50 EUR-2.5%54.11 EUR104.2 EUR1.41-16.071.1KOff
17 Jul 202667.15 EUR8.7%54.09 EUR104.5 EUR1.43-14.611.8KOff
10 Jul 202661.80 EUR-12.5%54.04 EUR104.7 EUR1.34-24.402.0KOff
3 Jul 202670.65 EUR10.1%54.08 EUR105.0 EUR1.16-16.00725Off
26 Jun 202664.15 EUR-3.8%53.79 EUR105.2 EUR0.98-23.12286Off
19 Jun 202666.65 EUR35.2%53.84 EUR105.4 EUR0.71-22.80100Off
12 Jun 202649.28 EUR1.1%53.64 EUR105.6 EUR0.42-41.33152Off
5 Jun 202648.72 EUR11.1%54.03 EUR105.9 EUR0.26-41.44604Off
29 May 202643.86 EUR-1.9%54.45 EUR106.1 EUR0.18-48.87100Off
22 May 202644.72 EUR-3.7%55.38 EUR106.5 EUR0.15-47.77312Off
15 May 202646.42 EUR5.0%56.56 EUR106.8 EUR0.13-46.191.0KOff
8 May 202644.20 EUR-8.9%57.82 EUR107.1 EUR0.02-50.243.1KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context